SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-028186
Filing Date
2024-07-17
Accepted
2024-07-17 16:30:15
Documents
1
Period of Report
2024-07-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4038
  Complete submission text file 0001493152-24-028186.txt   5538
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Issuer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1920 MCKINNEY AVENUE, 7TH FLOOR DALLAS TX 75201
Business Address
Margrave David R. (Reporting) CIK: 0001813162 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39318 | Film No.: 241122589